Impact of complete response on progression-free survival and overall survival in newly diagnosed myeloma patients treated with autologous stem cell transplantation or conventional chemotherapy: results of a pooled analysis of 5 phase III trials

R. Mina; A. Larocca; M. Offidani; V. Magarotto; T. Caravita; R. van der Holt; F. Di Raimondo; A. Bosi; I.D. Vincelli; S. Croockewit; G. Gaidano; S. Grandi; C. Musolino; C. Cerrato; P. Lud k; M. Ruggeri; G. Rossi; F. Rossini; M.T. Petrucci; R. Ria; S. Zweegman; R. Hajek; A. Spencer; M. Boccadoro; P. Sonneveld; A. Palumbo

Journal Article

Impact of complete response on progression-free survival and overall survival in newly diagnosed myeloma patients treated with autologous stem cell transplantation or conventional chemotherapy: results of a pooled analysis of 5 phase III trials

Mina R
Larocca A
Offidani M
et al.

Clinical Lymphoma Myeloma and Leukemia (2015) 15 e53-e54

DOI: 10.1016/j.clml.2015.07.192

N/ACitations

3Readers

Get full text

Cite

CITATION STYLE

APA

Mina, R., Larocca, A., Offidani, M., Magarotto, V., Caravita, T., van der Holt, R., … Palumbo, A. (2015). Impact of complete response on progression-free survival and overall survival in newly diagnosed myeloma patients treated with autologous stem cell transplantation or conventional chemotherapy: results of a pooled analysis of 5 phase III trials. Clinical Lymphoma Myeloma and Leukemia, 15, e53–e54. https://doi.org/10.1016/j.clml.2015.07.192

Impact of complete response on progression-free survival and overall survival in newly diagnosed myeloma patients treated with autologous stem cell transplantation or conventional chemotherapy: results of a pooled analysis of 5 phase III trials

Cite

Register to see more suggestions